Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak
Open Access
- 5 November 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (11) , e0142366
Abstract
We characterized 12 clinical isolates of Klebsiella oxytoca with the extended-spectrum β-lactamase (ESBL) phenotype (high minimum inhibitory concentration [MIC] values of ceftriaxone) recovered over 9 months at a university hospital in Japan. To determine the clonality of the isolates, we used pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and PCR analyses to detect blaRBI, which encodes the β-lactamase RbiA, OXY-2-4 with overproduce-type promoter. Moreover, we performed the isoelectric focusing (IEF) of β-lactamases, and the determination of the MICs of β-lactams including piperacillin/tazobactam for 12 clinical isolates and E. coli HB101 with pKOB23, which contains blaRBI, by the agar dilution method. Finally, we performed the initial screening and phenotypic confirmatory tests for ESBLs. Each of the 12 clinical isolates had an identical PFGE pulsotype and MLST sequence type (ST9). All 12 clinical isolates harbored identical blaRBI. The IEF revealed that the clinical isolate produced only one β-lactamase. E. coli HB101 (pKOB23) and all 12 isolates demonstrated equally resistance to piperacillin/tazobactam (MICs, >128 μg/ml). The phenotypic confirmatory test after the initial screening test for ESBLs can discriminate β-lactamase RbiA-producing K. oxytoca from β-lactamase CTX-M-producing K. oxytoca. Twelve clinical isolates of K. oxytoca, which were recovered from an outbreak at one university hospital, had identical genotypes and produced β-lactamase RbiA that conferred resistance to piperacillin/tazobactam. In order to detect K. oxytoca isolates that produce RbiA to promote research concerning β-lactamase RbiA-producing K. oxytoca, the phenotypic confirmatory test after the initial screening test for ESBLs would be useful.Keywords
This publication has 34 references indexed in Scilit:
- Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Klebsiella oxytoca in AustriaAntimicrobial Agents and Chemotherapy, 2012
- Outbreak of OXY-2-ProducingKlebsiella oxytocain a Renal Transplant UnitJournal of Clinical Microbiology, 2008
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Klebsiella oxytocaas a Causative Organism of Antibiotic-Associated Hemorrhagic ColitisNew England Journal of Medicine, 2006
- Six Groups of the OXY β-Lactamase Evolved over Millions of Years in Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 2005
- False-positive extended-spectrum -lactamase tests for Klebsiella oxytoca strains hyperproducing K1 -lactamaseJournal of Antimicrobial Chemotherapy, 2004
- New Klebsiella oxytoca β-Lactamase Genes bla OXY-3 and bla OXY-4 and a Third Genetic Group of K. oxytoca Based on bla OXY-3Antimicrobial Agents and Chemotherapy, 2003
- Antibiotic resistance and production of extended-spectrum β-Mactamases amongst Klebsiella spp. from intensive care units in EuropeJournal of Antimicrobial Chemotherapy, 1996
- Klebsiella oxytoca: Resistance to aztreonam by overproduction of the chromosomally encoded β-lactamaseFEMS Microbiology Letters, 1994
- Identification of -Lactamases by Analytical Isoelectric Focusing: Correlation with Bacterial TaxonomyJournal of General Microbiology, 1976